Form4insider filings, from the source

Insider holders · CIK 0001411158

Anacor Pharmaceuticals, Inc. · ANAC

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Geoffrey M. ParkerExecutive Vice President & CFO94,84010,000104,840Mar 23, 2015 · 6:55 pm EDTForm 4
Sanjay ChandaSVP, Drug Development29,087—29,087Mar 4, 2015 · 7:22 pm ESTForm 4
Jacob j PlattnerSenior VP, Research5,02017,84022,860May 15, 2015 · 8:18 pm EDTForm 4
Kirk R MaplesSVP, Program Management7,220—7,220Jun 2, 2015 · 8:00 pm EDTForm 4
Carmen R RodriguezSnr VP Reg Afrs & Qual. Assur.7,020—7,020May 14, 2015 · 9:11 pm EDTForm 4
Graeme BellExecutive VP and CFO0—0Jun 24, 2016 · 2:44 pm EDTForm 4
Ryan T SullivanEVP and General Counsel0—0Jun 24, 2016 · 2:41 pm EDTForm 4
Lee ZaneSVP and Chief Medical Officer0—0Jun 24, 2016 · 2:49 pm EDTForm 4
Lucy ShapiroDirector0—0Jun 24, 2016 · 3:04 pm EDTForm 4
Vincent P IppolitoEVP & Chief Commercial Officer0—0Jun 24, 2016 · 2:32 pm EDTForm 4
Keith R LeonardDirector0—0Jun 24, 2016 · 2:56 pm EDTForm 4
Anders D HoveDirector000Jun 24, 2016 · 3:36 pm EDTForm 4
Wendall WierengaDirector0—0Jun 24, 2016 · 2:55 pm EDTForm 4
Paul L BernsPresident and CEO0—0Jun 24, 2016 · 2:43 pm EDTForm 4
William Jl RieflinDirector000Jun 24, 2016 · 2:59 pm EDTForm 4
Mark LeschlyDirector0—0Jun 24, 2016 · 2:58 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.